« | Main | »

August 7, 2009

Patently Obvious: Simon @ Power and Control brings us this patent:
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3. ##STR1##

And who was granted this medically significant marijuana patent in 2003? The United States of America as represented by the Department of Health and Human Services of course.

Posted by Vanderleun at August 7, 2009 1:21 AM. This is an entry on the sideblog of American Digest: Check it out.

Your Say

Post a comment




Remember Me?

(you may use HTML tags for style)